CRISPR/Cas9-Mediated Gene Correction in Newborn Rabbits with Hereditary Tyrosinemia Type I

Lindstedt, 1992, Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase, Lancet, 340, 813, 10.1016/0140-6736(92)92685-9 St-Louis, 1997, Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview, Hum. Mutat., 9, 291, 10.1002/(SICI)1098-1004(1997)9:4<291::AID-HUMU1>3.0.CO;2-9 Russo, 1990, Visceral pathology of hereditary tyrosinemia type I, Am. J. Hum. Genet., 47, 317 Mayorandan, 2014, Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice, Orphanet J. Rare Dis., 9, 107, 10.1186/s13023-014-0107-7 Adam, 2012, Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR), J. Hepatol., 57, 675, 10.1016/j.jhep.2012.04.015 Mali, 2013, RNA-guided human genome engineering via Cas9, Science, 339, 823, 10.1126/science.1232033 Cong, 2013, Multiplex genome engineering using CRISPR/Cas systems, Science, 339, 819, 10.1126/science.1231143 Amoasii, 2018, Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy, Science, 362, 86, 10.1126/science.aau1549 Yang, 2016, A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice, Nat. Biotechnol., 34, 334, 10.1038/nbt.3469 Beyret, 2019, Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome, Nat. Med., 25, 419, 10.1038/s41591-019-0343-4 Santiago-Fernández, 2019, Development of a CRISPR/Cas9-based therapy for Hutchinson-Gilford progeria syndrome, Nat. Med., 25, 423, 10.1038/s41591-018-0338-6 Paulk, 2010, Adeno-associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo, Hepatology, 51, 1200, 10.1002/hep.23481 Yin, 2014, Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype, Nat. Biotechnol., 32, 551, 10.1038/nbt.2884 Yin, 2016, Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo, Nat. Biotechnol., 34, 328, 10.1038/nbt.3471 Song, 2020, Adenine base editing in an adult mouse model of tyrosinaemia, Nat. Biomed. Eng., 4, 125, 10.1038/s41551-019-0357-8 Shao, 2018, Cas9-nickase-mediated genome editing corrects hereditary tyrosinemia in rats, J. Biol. Chem., 293, 6883, 10.1074/jbc.RA117.000347 Jacobs, 2006, Kidneys of mice with hereditary tyrosinemia type I are extremely sensitive to cytotoxicity, Pediatr. Res., 59, 365, 10.1203/01.pdr.0000198810.57642.b4 Bosze, 2006, Application of rabbits in biomedical research: A review, World Rabbit Sci., 14, 1 Fan, 2003, Transgenic rabbits as therapeutic protein bioreactors and human disease models, Pharmacol. Ther., 99, 261, 10.1016/S0163-7258(03)00069-X Fan, 2015, Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine, Pharmacol. Ther., 146, 104, 10.1016/j.pharmthera.2014.09.009 Li, 2017, Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1, J. Biol. Chem., 292, 4755, 10.1074/jbc.M116.764787 Hickey, 2011, Efficient production of Fah-null heterozygote pigs by chimeric adeno-associated virus-mediated gene knockout and somatic cell nuclear transfer, Hepatology, 54, 1351, 10.1002/hep.24490 Hickey, 2014, Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease, Stem Cell Res. (Amst.), 13, 144, 10.1016/j.scr.2014.05.003 Hickey, 2016, Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1, Sci. Transl. Med., 8, 349ra99, 10.1126/scitranslmed.aaf3838 Nicolas, 2019, Ectopic hepatocyte transplantation cures the pig model of tyrosinemia, bioRxiv Wang, 2019, Adeno-associated virus vector as a platform for gene therapy delivery, Nat. Rev. Drug Discov., 18, 358, 10.1038/s41573-019-0012-9 Sands, 2011, AAV-mediated liver-directed gene therapy, Methods Mol. Biol., 807, 141, 10.1007/978-1-61779-370-7_6 Nakai, 2005, Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice, J. Virol., 79, 214, 10.1128/JVI.79.1.214-224.2005 Zhang, 2016, Efficient liver repopulation of transplanted hepatocyte prevents cirrhosis in a rat model of hereditary tyrosinemia type I, Sci. Rep., 6, 31460, 10.1038/srep31460 Anguela, 2015, In Vivo Genome Editing in Neonatal Mouse Liver Preferentially Utilizes Homology Directed Repair, Blood, 126, 4422, 10.1182/blood.V126.23.4422.4422 Bae, 2014, Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases, Bioinformatics, 30, 1473, 10.1093/bioinformatics/btu048 Waddington, 2004, Fetal and neonatal gene therapy: benefits and pitfalls, Gene Ther., 11, S92, 10.1038/sj.gt.3302375 Landrum, 2016, ClinVar: public archive of interpretations of clinically relevant variants, Nucleic Acids Res., 44, D862, 10.1093/nar/gkv1222